Vioxx Heart Risk Persists One Year After Stopping Use
A new international study found that Merck’s pain killer Vioxx (rofecoxib), which the drug company voluntarily withdrew from the market in 2004, found that a near two-fold increased risk of heart, stroke and death persisted for up to one year after stopping use.
More: continued here
Filed under: Arthritis on October 27th, 2008